Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVO NORDISK A/S
04/29 NOVO NORDISK A/S : Semaglutide significantly reduces the risk of major adverse c..
04/29 NOVO NORDISK A/S : Speakers for exploring new treatment options for diabetes
04/29DJNOVO NORDISK A/S : Trims Guidance on Currency Rates
04/29 NOVO NORDISK A/S : increased adjusted operating profit by 10% in local currencie..
04/28 NOVO NORDISK A/S : Marks World Hemophilia Day by Raising Awareness of Bleeding D..
04/28 NOVO NORDISK A/S : Study Data from Novo Nordisk Provide New Insights into Peptid..
04/28 NOVO NORDISK A/S : Researchers from Novo Nordisk Report Recent Findings in Struc..
04/28 NOVO NORDISK A/S : Share repurchase programme
04/28 NOVO NORDISK A/S : aktietilbagekøbsprogram
04/28 NOVO NORDISK A/S : - Total number of voting rights and share capital in Novo Nor..
04/28 NOVO NORDISK A/S : Semaglutide reduces the risk of major adverse cardiovascular ..
04/28 NOVO NORDISK A/S : Semaglutide significantly reduces the risk of major adverse c..
04/27 NOVO NORDISK A/S : Healthy Cities Need a Low Carbon Diet
04/27DJNovo Nordisk A/S 1Q 2016 -- Forecast
04/25 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
04/21 NOVO NORDISK A/S : New Toxicology Study Findings Have Been Reported by Researche..
04/21 NOVO NORDISK A/S : New Findings from Novo Nordisk Describe Advances in Rheumatoi..
04/21 NOVO NORDISK A/S : New Peptide Hormones Study Findings Have Been Reported by Inv..
04/21 NOVO NORDISK A/S : Study Data from Novo Nordisk Update Understanding of Essentia..
04/21 NOVO NORDISK A/S : Investigators at Novo Nordisk Discuss Findings in General Den..
04/21 NOVO NORDISK A/S : to invest EUR 100 million in production facilities
04/21 NOVO NORDISK A/S : plans to invest more than 100 million euros in production pla..
04/21 NOVO NORDISK A/S : plans to invest more than 100 million euros in production pla..
04/20 PRESSWIRE : Novo Nordisk featured in a pioneering Cambridge University Students&..
04/18 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
04/18 NOVO NORDISK A/S : Share repurchase programme
04/18 NOVO NORDISK A/S : Reduction of the share capital
04/14 NOVO NORDISK A/S : Victoza® liraglutide injection Provided Superior HbA1c Reduct..
04/14 NOVO NORDISK A/S : New Tauopathies Findings from Novo Nordisk Reported (The GLP-..
04/14 NOVO NORDISK A/S : Studies in the Area of Ion Channels Reported from Novo Nordis..
04/13 NOVO NORDISK A/S : Bringing the Doctor to the Doorstep in Mexico City
04/11 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
04/11 NOVO NORDISK A/S : gets green light
04/11 NOVO NORDISK A/S : Share repurchase programme
04/08 NOVO NORDISK A/S : A/S: Johannesburg joins Cities Changing Diabetes
04/04 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
04/04 NOVO NORDISK A/S : Saxenda® demonstrated significant improvements in cardiometab..
04/04 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
04/04 NOVO NORDISK A/S : Victoza® (liraglutide 1.8 mg) provided superior HbA1c reducti..
04/02 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares (31..
04/01 NOVO NORDISK A/S : Share repurchase programme
04/01 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares (31..
04/01 NOVO NORDISK A/S : Share repurchase programme
03/31 NOVO NORDISK A/S : Health in the City: Why Urbanisation can be a Risk Factor
03/29 NOVO NORDISK A/S : McCrory blames 'inaccurate' news stories for backlash against..
03/29 NOVO NORDISK A/S : breaks ground on $1.8B Clayton expansion
03/29 NOVO NORDISK A/S : breaks ground on USD 2bn production facility in Clayton, Nort..
03/29 EMISPHERE TECHNOLOGIES : Reports Fourth Quarter and Full Year 2015 Financial Res..
03/28 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
03/24 NNIT A/S : 4/2016 NNIT enters into agreement with DSB on a two year extension of..
03/21 NOVO NORDISK A/S : and Horizon Foundation for New Jersey Sign on as Presenting S..
03/21 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
03/21 NOVO NORDISK A/S : Share repurchase programme
03/21 NOVO NORDISK A/S : ex-dividend day for annual dividend
03/18 NOVO NORDISK A/S : Resolutions from the Annual General Meeting of Novo Nordisk A..
03/18 NOVO NORDISK A/S : Diabetes is no limit to cycling team's pedal power
03/17 NOVO NORDISK A/S : Victoza® Significantly Reduced the Risk of Major Adverse Card..
03/17 NOVO NORDISK A/S : Researchers from Novo Nordisk Describe Findings in Chemical E..
03/17 NOVO NORDISK A/S : Findings in Colitis Reported from Novo Nordisk (Treatment wit..
03/17 NOVO NORDISK A/S : Researchers Submit Patent Application, "Use of C5AR Antagonis..
03/17 NOVO NORDISK A/S : Team Novo Nordisk and Pioneer Electronics Announce Two-Year P..
03/14 NOVO NORDISK A/S : Share repurchase programme
03/10 NOVO NORDISK A/S : Inc. Named on the 2016 FORTUNE 100 Best Companies to Work For..
03/10 NOVO NORDISK A/S : Research Conducted at Novo Nordisk Has Provided New Informati..
03/07 NOVO NORDISK A/S : Share repurchase programme
03/05 NOVO NORDISK A/S : Victoza significantly reduces the risk of major adverse cardi..
03/04 NOVO NORDISK A/S : Study shows Victoza reduces the risk of major adverse cardiov..
03/04 NOVO NORDISK A/S : Victoza® significantly reduces the risk of major adverse card..
03/03 NOVO NORDISK A/S : New Drug-Induced Liver Injury Study Findings Have Been Report..
03/03 NOVO NORDISK A/S : Study Findings on Keratinocytes Are Outlined in Reports from ..
03/03 NOVO NORDISK A/S : Studies from Novo Nordisk Yield New Data on Immunoglobulins (..
03/03 NOVO NORDISK A/S : Xultophy cost-effective versus current basal insulin intensif..
03/01 Novo Nordisk and AstraZeneca seek tonic from key drug trials
02/29 NOVO NORDISK A/S : Share repurchase programme
02/26 NOVO NORDISK A/S : impact greater than anticipated
1  2  3  4  5  6  7  8  9  10Next
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials